Sarah Ketterer Causeway Capital Management
Sarah Ketterer is co-founder and CEO of Causeway Capital Management, a firm specializing in international and global value equities. Causeway is known for disciplined valuation work across developed and emerging markets. Ketterer’s commentary is often sought for perspective on non-U.S. equities, currencies, and relative value abroad.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$364M |
| 2 |
Deutsche Bank
DB
|
+$142M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$112M |
| 4 |
NetEase
NTES
|
+$67.6M |
| 5 |
Boston Scientific
BSX
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$178M |
| 2 |
Whirlpool
WHR
|
+$64.8M |
| 3 |
Cognizant
CTSH
|
+$53.2M |
| 4 |
Aptiv
APTV
|
+$47.5M |
| 5 |
BP
BP
|
+$41.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.55% |
| 2 | Consumer Discretionary | 22.18% |
| 3 | Financials | 19.31% |
| 4 | Industrials | 12.93% |
| 5 | Technology | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zimmer Biomet
ZBH
$19.3B
| $67.9M | 0.74% |
788,810
-19,300
| -2% | -$1.69M |
|
27
Boeing
BA
$169B
| $67.8M | 0.73% |
313,048
-878
| -0.3% | -$195K |
|
28
Citigroup
C
$221B
| $64.2M | 0.7% |
458,858
-176,073
| -28% | -$22.9M |
|
29
NatWest
NWG
$74B
| $61.5M | 0.67% |
3,487,290
+498,981
| +17% | +$8.02M |
|
30
Biogen
BIIB
$32B
| $60.1M | 0.65% |
278,283
-2,500
| -0.9% | -$478K |
|
31
Gold Fields
GFI
$42.8B
| $57.5M | 0.62% |
1,713,233
+79,063
| +5% | +$3.29M |
|
32
Analog Devices
ADI
$182B
| $56.4M | 0.61% |
142,050
-59,769
| -30% | -$23.7M |
|
33
RELX
RELX
$62.6B
| $55.8M | 0.6% |
1,762,329
-544,080
| -24% | -$18.4M |
|
34
AngloGold Ashanti
AU
$61.3B
| $55.7M | 0.6% |
688,027
-210,789
| -23% | -$20M |
|
35
ING
ING
$99.5B
| $53.1M | 0.57% |
1,690,687
+152,939
| +10% | +$4.52M |
|
36
Booz Allen Hamilton
BAH
$9.27B
| $51.6M | 0.56% |
849,966
-7,496
| -0.9% | -$572K |
|
37
Texas Instruments
TXN
$241B
| $49.6M | 0.54% |
166,496
-39,718
| -19% | -$11M |
|
38
National Grid
NGG
$80.2B
| $48.9M | 0.53% |
590,240
+51,479
| +10% | +$4.38M |
|
39
DTE Energy
DTE
$28.1B
| $48.8M | 0.53% |
320,526
-1,489
| -0.5% | -$218K |
|
40
Pfizer
PFE
$160B
| $46.2M | 0.5% |
1,916,801
+2,582
| +0.1% | +$67.5K |
|
41
Petrobras Class A
PBR.A
$111B
| $45.3M | 0.49% |
3,096,624
+1,600,960
| +107% | +$28.2M |
|
42
Prudential
PUK
$35B
| $45.3M | 0.49% |
1,689,218
+368,067
| +28% | +$10.7M |
|
43
Smith & Nephew
SNN
$12.2B
| $45.1M | 0.49% |
1,565,167
+612,021
| +64% | +$19M |
|
44
TAL Education Group
TAL
$6.28B
| $39.5M | 0.43% |
4,125,430
+647,013
| +19% | +$6.8M |
|
45
iShares MSCI India Small-Cap ETF
SMIN
$771M
| $38.4M | 0.42% |
542,849
+71,195
| +15% | +$4.75M |
|
46
UnitedHealth
UNH
$350B
| $36.3M | 0.39% |
87,447
+15,583
| +22% | +$5.78M |
|
47
Walt Disney
DIS
$186B
| $34.7M | 0.38% |
360,600
-199,282
| -36% | -$20.3M |
|
48
Sanofi
SNY
$110B
| $34.3M | 0.37% |
804,056
-260,460
| -24% | -$11.6M |
|
49
British American Tobacco
BTI
$121B
| $33.8M | 0.37% |
547,925
+47,061
| +9% | +$2.84M |
|
50
Sumitomo Mitsui Financial
SMFG
$159B
| $32.8M | 0.36% |
1,392,610
+125,362
| +10% | +$2.78M |
|
Similar funds
Sarah Ketterer's Q2 2026 Portfolio in Review
As of Q2 2026, Sarah Ketterer held 129 positions worth $9.24B, up 13% from $8.15B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Sarah Ketterer deployed $508M of net new capital in Q2 2026, opening 22 new positions and adding to 49 existing holdings. Its largest new stake was NetEase: 572,412 shares worth $73.3M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Canadian Pacific Kansas City, an estimated $178M trimmed.
- Sarah Ketterer's largest Q2 2026 buy was NetEase: 572,412 shares worth $73.3M.
- Sarah Ketterer added most to AstraZeneca in Q2 2026, an estimated $364M increase.
- Sarah Ketterer's biggest Q2 2026 reduction was Canadian Pacific Kansas City, cutting an estimated $178M.
- Sarah Ketterer fully exited Whirlpool in Q2 2026, selling an estimated $64.8M.
- Sarah Ketterer's ten largest holdings make up 65% of its $9.24B portfolio in Q2 2026.
- Sarah Ketterer opened 22 new positions and closed 7 in Q2 2026.
- Sarah Ketterer's portfolio value rose 13% quarter-over-quarter to $9.24B.
Based on Causeway Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.